Efficacy of a Cellular Allogeneic Bone Graft in Foot and Ankle Arthrodesis Procedures.

Journal Article (Journal Article)

A cellular allogeneic bone graft can be used in patients at high risk for nonunion after arthrodesis surgery. This study explores the utility and efficacy of MAP3 in foot and ankle arthrodesis procedures. Map3 is a cellular allogeneic bone graft that contains osteogenic, osteoconductive, osteoinductive, and angiogenic properties. A total of 23 mostly high-risk patients were included in this study. The overall fusion rate was 83%. Univariate analysis demonstrated diabetic patients remain at risk of recurrent nonunion (P<.001) despite supplementation with MAP3. These data demonstrate successful fusion in high-risk patients when MAP3 is used.

Full Text

Duke Authors

Cited Authors

  • Dekker, TJ; White, P; Adams, SB

Published Date

  • December 2016

Published In

Volume / Issue

  • 21 / 4

Start / End Page

  • 855 - 861

PubMed ID

  • 27871418

Electronic International Standard Serial Number (EISSN)

  • 1558-1934

Digital Object Identifier (DOI)

  • 10.1016/j.fcl.2016.07.008


  • eng

Conference Location

  • United States